Manufacturing License for Class C & D Medical Devices under CDSCO and MDR 2017

India’s medical device industry continues to grow at a steady pace, and Class C and Class D products sit at the higher end of the risk scale. These devices—such as ventilators, dialysis systems, implantable products, and sophisticated diagnostic equipment—can have a direct impact on patient safety. The framework that governs them is the Medical Devices Rules, 2017. Under these Rules, the Central Drugs Standard Control Organisation has assigned the task of licensing Class C and Class D devices exclusively to the Central Licensing Authority. This article explains the full process of securing a manufacturing licence for these higher-risk devices, covering the essential requirements, documents, procedural steps, and practical points that manufacturers and regulatory teams need to keep in mind.

Understanding Class C and Class D Devices

MDR 2017 divides medical devices into four risk-based groups. Class C covers moderate-to-high risk products, while Class D covers the highest-risk category. Typical examples are cardiac stents, orthopaedic implants, life-support systems, and certain in-vitro diagnostic reagents that could cause serious harm if they malfunction. Because of this risk profile, manufacturing licences for these devices cannot be issued by State Licensing Authorities. Only the Central Licensing Authority (headed by the Drugs Controller General of India at CDSCO) has the power to grant them.

The difference between Class A/B and Class C/D is therefore more than administrative. It decides how deeply the technical file is examined, how thorough the site inspection will be, and how rigorously the quality system is assessed.

Legal Framework and Application Forms

Rule 21 of the Medical Devices Rules, 2017 sets out the procedure for applying to manufacture Class C or Class D devices. Manufacturers submit Form MD-7 for a standard manufacturing licence or Form MD-8 when they wish to obtain a loan licence (manufacture at a third-party site under their own responsibility). After successful evaluation, the Central Licensing Authority issues the licence in Form MD-9 (standard) or Form MD-10 (loan).

Every application must be filed electronically through the CDSCO Medical Devices Online Portal or the National Single Window System. Physical paper submissions are not accepted.

Key Prerequisites before Filing

Several foundational conditions must be satisfied before an application is treated as complete:

1. Quality Management System The manufacturing site must run a quality management system that meets the requirements listed in the Fifth Schedule of MDR 2017 (closely aligned with ISO 13485). The applicant has to give a formal undertaking of full compliance and supply supporting documents such as the Quality Manual, document-control procedures, statements on management responsibility, resource management, production controls, internal audits, non-conformance handling, and corrective-and-preventive-action procedures.
2. Competent Technical Staff Rule 22 requires the appointment of suitably qualified technical personnel to supervise manufacturing and testing. A person holding a degree in a relevant branch of engineering, pharmacy or science, together with at least two years of experience in manufacturing or testing medical devices (or a diploma holder with four years of experience), must oversee production. A separate qualified person must supervise testing activities.
3. Premises and Infrastructure The site must be adequate in size, construction and layout for the intended operations. Clean-room classifications, environmental controls and segregation of areas must match the specifications given in Annexure A of the Fifth Schedule. Proof of legal occupation of the premises (ownership or tenancy documents) is required.

Documentation Package

The Fourth Schedule (Part II, clause ii) of MDR 2017 lists the documents that must accompany Form MD-7. In day-to-day practice the CDSCO checklists organise these documents under the following main headings:

• Covering letter and completed Form MD-7
• Fee challan (₹50,000 for one manufacturing site plus ₹1,000 for each distinct device)
• Constitution documents of the firm
• Site ownership or tenancy agreement
• Plant Master File prepared according to Appendix I of the Fourth Schedule (facility overview, organisation chart, staff qualifications, premises description, scaled plant layout, equipment list, sanitation, production, quality assurance, storage and documentation systems)
• Device Master File prepared according to Appendix II (or Appendix III for IVDs), containing an executive summary, device description, specifications, labelling, design and manufacturing information, risk-management summary, design verification and validation, biocompatibility data, sterilisation validation where applicable, software validation if relevant, stability data and clinical evidence
• Undertaking of QMS compliance with the Fifth Schedule
• Quality Manual and related QMS procedures
• Environmental-control table as required by Annexure A of the Fifth Schedule
• Performance evaluation reports (for IVDs)
• Post-market surveillance data for the previous years (if the device is already marketed elsewhere)
• Permission in Form MD-27 when the device has no predicate in India

Devices without a predicate may also need clinical-investigation data generated in India under Chapter VII of the Rules.

Step-by-Step Licensing Process

1. Confirm the risk class using the CDSCO notified lists and the classification rules in the First Schedule.
2. Register on the CDSCO Medical Devices Online Portal, pay the prescribed fees and upload the complete documentation set.
3. The Central Licensing Authority scrutinises the dossier. Any deficiencies are raised online and must be answered within the given time.
4. Under Rule 23 the manufacturing site is inspected within 60 days of receipt of a complete application. The inspection team consists of at least two Medical Device Officers and may include a subject-matter expert or a registered Notified Body. The team verifies physical compliance with the Plant Master File, QMS implementation and environmental controls.
5. Once the inspection report is received, the Central Licensing Authority has 45 days to grant the licence in Form MD-9 (or MD-10) or to reject the application with written reasons. From complete submission to final licence the process usually takes several months and can extend beyond a year, depending on device complexity and site readiness.

Post-Licence Obligations

After the manufacturing licence is granted the licence holder must:

• Keep the quality management system and premises in continuous compliance
• Report any change in constitution, technical staff or manufacturing process as required by the Rules
• Maintain a functioning post-market surveillance and vigilance system
• Pay the retention fee (same amount as the original site and product fees) before the end of the validity period
• Ensure every batch is manufactured and tested under the supervision of the approved technical staff

Non-compliance can lead to suspension or cancellation of the licence.

Practical Challenges and How to Address Them

Common causes of delay include incomplete Device Master Files, missing clean-room validation data, or insufficient clinical evidence for novel devices. Early engagement with a regulatory consultant who regularly handles CDSCO filings helps identify gaps before submission. A pre-inspection gap assessment against the Fifth Schedule and the Fourth Schedule checklists markedly improves the chance of a successful first inspection.

Correct grouping of devices is another frequent issue. Devices that share the same generic name, intended use and material of construction may be grouped, yet each distinct device still attracts the ₹1,000 fee. Accurate grouping reduces administrative effort without compromising compliance.

Why Professional Support Matters

Securing a Class C or Class D manufacturing licence requires simultaneous attention to technical, quality and regulatory requirements. Preparing Plant and Device Master Files that meet CDSCO expectations, coordinating site inspections and responding promptly to queries all benefit from specialised expertise. Regulatory consultants who work regularly with the CDSCO Medical Devices Division can convert the formal requirements of the Medical Devices Rules, 2017 into practical, audit-ready documentation and procedures.

How MDR Consultants Can Help with Class C & D Manufacturing Licences?

Obtaining a Class C or Class D medical-device manufacturing licence involves much more than completing Form MD-7. The regulatory dossier, manufacturing facility, QMS, technical personnel and device evidence must work together as a coherent compliance system. MDR Consultants can help you will the following:

1. Regulatory Classification and Strategy

2. CDSCO Application Preparation

3. QMS Development and Implementation

4. Manufacturing-Site Gap Assessment

5. Technical Documentation Support

6. CDSCO Query Management

7. Inspection Readiness

8. Post-Licensing Regulatory Support

Conclusion

Obtaining a manufacturing licence for Class C and Class D medical devices under the Medical Devices Rules, 2017 is a rigorous but clearly defined process intended to protect public health. By establishing full quality-system compliance, appointing qualified technical staff, compiling comprehensive Plant and Device Master Files, and successfully completing the mandatory site inspection, Indian manufacturers can obtain the Form MD-9 licence that authorises commercial production and distribution. Careful preparation and a clear understanding of CDSCO expectations set out in the Rules and their schedules are the keys to timely approval. Organisations that invest in regulatory readiness from the start not only secure faster licences but also create a solid foundation for ongoing compliance and market credibility in India’s expanding medical-device sector.

Last Updated : 22 Aug 2026